| Product NDC: | 18860-324 |
| Proprietary Name: | Niravam |
| Non Proprietary Name: | alprazolam |
| Active Ingredient(s): | 2 mg/1 & nbsp; alprazolam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 18860-324 |
| Labeler Name: | Jazz Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021726 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050401 |
| Package NDC: | 18860-324-01 |
| Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (18860-324-01) |
| NDC Code | 18860-324-01 |
| Proprietary Name | Niravam |
| Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (18860-324-01) |
| Product NDC | 18860-324 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alprazolam |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20050401 |
| Marketing Category Name | NDA |
| Labeler Name | Jazz Pharmaceuticals, Inc. |
| Substance Name | ALPRAZOLAM |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |